InMode Ltd - Asset Resilience Ratio
InMode Ltd (INMD) has an Asset Resilience Ratio of 32.98% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read INMD current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how InMode Ltd's Asset Resilience Ratio has changed over time. See InMode Ltd book value and equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down InMode Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see INMD market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $252.79 Million | 32.98% |
| Total Liquid Assets | $252.79 Million | 32.98% |
Asset Resilience Insights
- Very High Liquidity: InMode Ltd maintains exceptional liquid asset reserves at 32.98% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
InMode Ltd Industry Peers by Asset Resilience Ratio
Compare InMode Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Beijing Wandong Medical Technology Co Ltd
SHG:600055 |
Medical Devices | 4.92% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
MODULIGHT OY EO 1
F:78W |
Medical Devices | 22.31% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.39% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Nova EYE Medical Ltd
AU:EYE |
Medical Devices | 11.08% |
Annual Asset Resilience Ratio for InMode Ltd (2016–2025)
The table below shows the annual Asset Resilience Ratio data for InMode Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 32.98% | $252.79 Million | $766.43 Million | -23.17pp |
| 2024-12-31 | 56.15% | $441.14 Million | $785.67 Million | -13.03pp |
| 2023-12-31 | 69.18% | $597.19 Million | $863.29 Million | -0.63pp |
| 2022-12-31 | 69.81% | $449.84 Million | $644.41 Million | -2.87pp |
| 2021-12-31 | 72.67% | $347.78 Million | $478.54 Million | +7.89pp |
| 2020-12-31 | 64.78% | $191.60 Million | $295.76 Million | -3.28pp |
| 2019-12-31 | 68.06% | $148.63 Million | $218.38 Million | +22.94pp |
| 2018-12-31 | 45.13% | $36.58 Million | $81.06 Million | +26.24pp |
| 2017-12-31 | 18.88% | $7.45 Million | $39.44 Million | +9.25pp |
| 2016-12-31 | 9.63% | $1.59 Million | $16.49 Million | -- |
About InMode Ltd
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simulta… Read more